Lancet Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Lancet Oncology
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jun 20, 2024, 12:25 |
Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
May 14, 2024, 09:21 |
Drugs
Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer
Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…
May 10, 2024, 16:58 |
Insight
The first tumor-agnostic study of a HER2-directed antibody-drug conjugate - MSKCC
Memorial Sloan Kettering Cancer Center (MSKCC) shared on LinkedIn: "Lead author Dr. Bob Li, a…
May 10, 2024, 12:42 |
Dialogues
OncoThon: Childhood Cancer with Gevorg Tamamyan, Khaled Ghanem, Jaume Mora, Leo Kager
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 5, 2024, 10:26 |
Insight
Piotr Wysocki: Older age is a negative prognostic factor in endometrial cancer
Piotr Wysocki recently shared on LinkedIn: "Wakkerman FC et al. published in Lancet Oncology an…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 15, 2024, 14:41 |
Drugs
Piotr Wysocki: The [177Lu]Lu-PSMA-617 plus enzalutamide combination is active and safe in mCRPC patients, but is it really an option for first-line treatment?
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 24, 2024, 08:36 |
Blog
David Collingridge: Delighted to be acting as co-lead of the Abstract Programme at this year's World Cancer Congress
David Collingridge, Editor-in-Chief at The Lancet Oncology, shared a post by the Union of International…
Feb 29, 2024, 05:24 |
Insight
Fadila Kouhen: Thrilled to have published my insights on concomitant immunotherapy and radiotherapy in cervical cancer
Fadila Kouhen, Associate Professor at Cheikh Khalifa International University Hospital, shared on LinkedIn: "Thrilled to…
Oct 17, 2023, 12:46 |
Blog
Lancet Oncology: Amidst the violence and increasing numbers of civilian deaths and casualties in Israel and Gaza, individuals with cancer face the harrowing prospect of losing access not just to life-saving treatment, but to any care at all.
Jul 16, 2023, 23:07 |
Societies
The Common Sense Oncology movement aims to redirect oncology back to what really matters to patients - Aaron Goodman
Introducing Common Sense Oncology! The Common Sense Oncology movement aims to redirect oncology back to…
All:
12
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube